Cholelithiasis in Infants: Risk Factors, Management, and the Role of Ursodeoxycholic Acid
UDCA should not be used routinely in children, especially infants, except in symptomatic children with a contraindication to surgery or to reduce clinical symptoms. In the absence of symptoms, patients may be monitored clinically.
Authors
- Gülin Erdemır (ORCID: https://orcid.org/0000-0002-9726-8219)
- Sedef Alpdoğan (ORCID: https://orcid.org/0000-0002-9157-9892)
- Özlem Bekem
- Çiğdem Ömür Ecevıt (ORCID: https://orcid.org/0000-0002-3980-8686)
- Duygu Demirtaş (ORCID: https://orcid.org/0000-0002-3662-4355)
- Mehmet Önder (ORCID: https://orcid.org/0000-0002-9354-5530)
- Cahit Barış Erdur (ORCID: https://orcid.org/0000-0001-7652-5960)
- Sevim Çakar (ORCID: https://orcid.org/0000-0001-5129-0923)
- Şafak Pelek
Institutions
- Dokuz Eylül University (TR)
- Ege University (TR)
- Dr. Behçet Uz Çocuk Hastalıkları Hastanesi (TR)
- Sağlık Bilimleri Üniversitesi (TR)
Publication Details
- Journal
- Children
- Published
- 2024-12-21
- DOI
- https://doi.org/10.3390/children11121553
- Citations
- 3
- Primary Topic
- Pediatric Hepatobiliary Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.72